MAURICIO PABLO SICA
Áreas de investigación, desarrollo y/o tecnología
- Biofíca de proteínas, Inmunología
Publicaciones y/o Actividades Tecnológicas
- M. Sica, M. Roussel, and P. Legembre (2025). “CD95/Fas stoichiometry in future precision medicine”. In: Cell Death & Differentiation, pp. 1–8
- M. E. Maccari, P. Schneider, C. R. Smulski, A. Meinhardt, F. Pinto, L. I. Gonzalez-Granado,C. Schuetz, M. P. Sica, M. Gross, I. Fuchs, et al. (2023). “Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations”. In: Journal of Allergy and Clinical Immunology
- S. Zenke, M. P. Sica, F. Steinberg, J. Braun, A. Zink, A. Gavrilov, A. Hilger, A. Arra, M. Brunner-Weinzierl, R. Elling, et al. (2022). “Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation”. In: Nature Communications 13.1, p. 6459
- M. P. Sica, M. V. Kortsarz, A. A. Morillas, and C. R. Smulski (2022). “Protocol to study the oligomeric organization of single-span transmembrane peptides using molecular dynamics simulations”. In: STAR protocols 3.3, p. 101636
- M. P. Sica and C. R. Smulski (2021). “Coarse grained molecular dynamic simulations for the study of TNF receptor family members’ transmembrane organization”. In: Frontiers in Cell andDevelopmental Biology 8, p. 577278